Patent intelligence · US
US 2014271721
PEANUT FORMULATIONS AND USES THEREOF
PEANUT FORMULATIONS AND USES THEREOF
Patent details — US 2014271721
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 18, 2014
- Expiration
- Sep 13, 2034
- Applicant
- ALLERGEN RES CORP [US]
- CPC classes
- A61K 39/ 00 A I, A61K 39/ 35 A I, A61K 39/ 38 A I, A61K/3935
Quick answer
US 2014271721 (PEANUT FORMULATIONS AND USES THEREOF) is held by ALLERGEN RES CORP [US]. Status: granted. Granted Sep 18, 2014. Expires Sep 13, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALLERGEN RES CORP [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 39/ 00 A I, A61K 39/ 35 A I, A61K 39/ 38 A I, A61K/3935, A61K/94816, A61K/9485
More from ALLERGEN RES CORP [US]
Related pharmaceutical patents in our USPTO index.
-
CN 112638413
Oral immunotherapy unit dose dispensing systems and methods
granted -
WO 2015187736
FORMULATIONS PLACEBO ET UTILISATIONS DE CELLES-CI
granted -
US 2014356438
PERIPHERALLY ADMINISTERED VISCOUS FORMULATIONS
granted -
US 2014271836
MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
granted -
US 2013209398
CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS AND METHODS OF USE
granted -
CA 2849366
COMPOSITIONS ET PROCEDES POUR TRAITER LA PRESBYTIE, L'HYPERMETROPIE LEGERE ET L'ASTIGMATISME IRREGULIER
granted -
US 2012003230
SUSTAINED RELEASE DRUG DELIVERY SYSTEMS COMPRISING A WATER SOLUBLE THERAPEUTIC AGENT AND A RELEASE MODIFIER
granted
Frequently asked questions
What is US patent 2014271721?
US 2014271721 (PEANUT FORMULATIONS AND USES THEREOF) is held by ALLERGEN RES CORP [US]. Status: granted. Granted Sep 18, 2014. Expires Sep 13, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2014271721?
ALLERGEN RES CORP [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 24 pharmaceutical patents for this assignee.
When does US 2014271721 expire?
Our index shows an expiration date of Sep 13, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.